Complications and Readmissions After Reverse and Anatomic Total Shoulder Arthroplasty With Same-day Discharge
- PMID: 32501854
- DOI: 10.5435/JAAOS-D-20-00245
Complications and Readmissions After Reverse and Anatomic Total Shoulder Arthroplasty With Same-day Discharge
Abstract
Background: Recent studies have demonstrated the safety of anatomic total shoulder arthroplasty (TSA) in an outpatient setting. No clinical studies, to date, have specifically analyzed complication and readmission rates after reverse total shoulder arthroplasty (RTSA) with same-day discharge. The purpose of this study was to compare the 90-day complication and readmission rates of patients undergoing TSA and RTSA with same-day discharge.
Methods: Ninety-eight consecutive patients who underwent 104 shoulder arthroplasties with same-day discharge (52 TSA and 52 RTSA) between 2016 and 2019 were analyzed. Suitability for same-day discharge was determined preoperatively using the standardized criteria. Demographic variables, operative time, 90-day readmission, and complication rates were recorded and compared between groups. Differences between the patients undergoing TSA versus RTSA were evaluated with Student t-test, Mann-Whitney test, or Chi square tests as statistically appropriate and reported as P values.
Results: Average age in the TSA cohort was significantly lower (60.1 ± 7.4 versus 67.5 ± 7.5, respectively; P < 0.001). Total operating room time was significantly shorter in the RTSA cohort (153 ± 30.1 minutes versus 171 ± 20.9). Three minor postoperative complications (5.8%) were observed in the TSA cohort (three seromas) within the 90-day postoperative period. There were four postoperative complications (7.7%) in the RTSA cohort (two postoperative seromas, one periprosthetic fracture, and one dislocation). None of the TSA patients required readmission and 1 RTSA (periprosthetic fracture) patient required readmission within 90 days.
Discussion: RTSA with same-day discharge is a safe option for appropriately selected patients despite significantly increased age. 90-day readmission and complication rates between outpatient TSA and RTSA are similar.
Data availability: Yes.
Trial registration numbers: NA.
Level of evidence: III (case-control).
Copyright © 2020 by the American Academy of Orthopaedic Surgeons.
References
-
- Brolin TJ, Cox RM, Zmistowski BM, Namdari S, Williams GR, Abboud JA: Surgeons' experience and perceived barriers with outpatient shoulder arthroplasty. J Shoulder Elbow Surg 2018;27:82-87.
-
- Charles MD, Cvetanovich G, Sumner-Parilla S, Nicholson GP, Verma N, Romeo AA: Outpatient shoulder arthroplasty: Outcomes, complications, and readmissions in 2 outpatient settings. J Shoulder Elbow Surg 2019:28:118-123.
-
- Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM: Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg 2010;19:1115-1120.
-
- Padegimas EM, Maltenfort M, Lazarus MD, Ramsey ML, Williams GR, Namdari S: Future patient demand for shoulder arthroplasty by younger patients: National projections. Clin Orthop Relat Res 2015;473:1860-1867.
-
- Basques BA, Erickson BJ, Leroux T, et al.: Comparative outcomes of outpatient and inpatient total shoulder arthroplasty: An analysis of the Medicare dataset. Bone Joint J 2017;99-B:934-938.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials